Entity usage
From MaRDI portal
This page lists pages that use the given entity (e.g. Q42). The list is sorted by descending page ID, so that newer pages are listed first.
Showing below up to 6 results in range #1 to #6.
- Continuous Glucose Monitoring and Intensive Treatment of Type 1 Diabetes: Label: en
- Vemurafenib in Multiple Nonmelanoma Cancers with BRAF V600 Mutations: Label: en
- New Creatinine- and Cystatin C–Based Equations to Estimate GFR without Race: Label: en
- Pembrolizumab plus Chemotherapy in Lung Cancer: Label: en
- Tissue Plasminogen Activator for Acute Ischemic Stroke: Label: en
- A Five-Gene Signature and Clinical Outcome in Non–Small-Cell Lung Cancer: Label: en